Loading...

Pharnext SA

ALPHA.PA•EURONEXT
Healthcare
Biotechnology
€0.00
€0.00(0.00%)

Pharnext SA (ALPHA.PA) Stock Overview

Explore Pharnext SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.9/100

Key Financials

Market Cap1.2K
P/E Ratio-0.00
EPS (TTM)$-200.00
ROE0.83%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$28287371.04

ALPHA.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pharnext SA (ALPHA.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $28287371.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 1.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;